WallStSmart

Accenture plc (ACN)vsConcentrix Corporation (CNXC)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Accenture plc generates 644% more annual revenue ($74.18B vs $9.97B). ACN leads profitability with a 11.3% profit margin vs -24.0%. CNXC appears more attractively valued with a PEG of 0.38. ACN earns a higher WallStSmart Score of 73/100 (B).

ACN

Strong Buy

73

out of 100

Grade: B

Growth: 6.7Profit: 8.0Value: 5.3Quality: 6.5
Piotroski: 4/9Altman Z: 2.66

CNXC

Buy

56

out of 100

Grade: C

Growth: 6.7Profit: 4.0Value: 8.3Quality: 3.5
Piotroski: 4/9Altman Z: 0.92
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ACNSignificantly Overvalued (-23.5%)

Margin of Safety

-23.5%

Fair Value

$201.86

Current Price

$247.28

$45.42 premium

UndervaluedFair: $201.86Overvalued
CNXCUndervalued (+60.6%)

Margin of Safety

+60.6%

Fair Value

$88.15

Current Price

$30.34

$57.81 discount

UndervaluedFair: $88.15Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACN5 strengths · Avg: 8.4/10
Market CapQuality
$144.99B9/10

Large-cap with strong market position

Return on EquityProfitability
26.6%9/10

Every $100 of equity generates 27 in profit

P/E RatioValuation
17.5x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
46.4%8/10

Earnings expanding 46.4% YoY

Free Cash FlowQuality
$2.85B8/10

Generating 2.8B in free cash flow

CNXC3 strengths · Avg: 9.3/10
PEG RatioValuation
0.3810/10

Growing faster than its price suggests

Price/BookValuation
1.0x10/10

Reasonable price relative to book value

EPS GrowthGrowth
36.1%8/10

Earnings expanding 36.1% YoY

Areas to Watch

ACN0 concerns · Avg: 0/10

No major concerns identified

CNXC4 concerns · Avg: 2.3/10
Market CapQuality
$1.87B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-47.6%2/10

ROE of -47.6% — below average capital efficiency

Revenue GrowthGrowth
-1.2%2/10

Revenue declined 1.2%

Altman Z-ScoreHealth
0.922/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : ACN

The strongest argument for ACN centers on Market Cap, Return on Equity, P/E Ratio. PEG of 1.33 suggests the stock is reasonably priced for its growth.

Bull Case : CNXC

The strongest argument for CNXC centers on PEG Ratio, Price/Book, EPS Growth. PEG of 0.38 suggests the stock is reasonably priced for its growth.

Bear Case : ACN

No major red flags identified for ACN, but monitor valuation.

Bear Case : CNXC

The primary concerns for CNXC are Market Cap, Return on Equity, Revenue Growth. Debt-to-equity of 2.47 is elevated, increasing financial risk.

Key Dynamics to Monitor

ACN profiles as a value stock while CNXC is a turnaround play — different risk/reward profiles.

ACN carries more volatility with a beta of 1.10 — expect wider price swings.

ACN is growing revenue faster at 6.2% — sustainability is the question.

ACN generates stronger free cash flow (2.8B), providing more financial flexibility.

Bottom Line

ACN scores higher overall (73/100 vs 56/100). CNXC offers better value entry with a 60.6% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Accenture plc

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

Accenture plc is an Irish-domiciled multinational company that provides consulting and processing services. It has been incorporated in Dublin, Ireland since 2009.

Concentrix Corporation

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

Concentrix Corporation offers global technology customer experience solutions. The company is headquartered in Fremont, California.

Visit Website →

Want to dig deeper into these stocks?